Artichoke, cynarin and cyanidin downregulate the expression of inducible nitric oxide synthase in human coronary smooth muscle cells

Molecules

Volumn 19, Issue 3, 2014, Pages 3654-3668

  Xia, Ning ^a   Pautz, Andrea ^a   Wollscheid, Ursula ^a   Reifenberg, Gisela ^a   Förstermann, Ulrich ^a   Li, Huige ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Artichoke; Cynara scolymus L; Inducible NO synthase; Nitric oxide; Vascular smooth muscle cells

Indexed keywords

ANTHOCYANIN; CINNAMIC ACID DERIVATIVE; CYANIDIN; CYNARINE; INDUCIBLE NITRIC OXIDE SYNTHASE; PLANT EXTRACT;

ARTICHOKE; ARTICLE; CELL CULTURE; CHEMISTRY; CORONARY BLOOD VESSEL; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PLANT LEAF; PROMOTER REGION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANTHOCYANINS; CELLS, CULTURED; CINNAMATES; CORONARY VESSELS; CYNARA SCOLYMUS; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE SYNTHASE TYPE II; PLANT EXTRACTS; PLANT LEAVES; PROMOTER REGIONS, GENETIC;

EID: 84896940552     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19033654     Document Type: Article

References (60)

1. Li, H.; Forstermann, U. Prevention of atherosclerosis by interference with the vascular nitric oxide system. Curr. Pharm. Des. 2009, 15, 3133-3145.
2. Li, H.; Forstermann, U. Nitric oxide in the pathogenesis of vascular disease. J. Pathol. 2000, 190, 244-254.
3. Liu, V.W.; Huang, P.L. Cardiovascular roles of nitric oxide: A review of insights from nitric oxide synthase gene disrupted mice. Cardiovasc. Res. 2008, 77, 19-29.
4. Gunnett, C.A.; Lund, D.D.; McDowell, A.K.; Faraci, F.M.; Heistad, D.D. Mechanisms of inducible nitric oxide synthase-mediated vascular dysfunction. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 1617-1622.
5. Chen, S.J.; Li, S.Y.; Shih, C.C.; Liao, M.H.; Wu, C.C. NO contributes to abnormal vascular calcium regulation and reactivity induced by peritonitis-Associated septic shock in rats. Shock 2010, 33, 473-478.
6. Shelkovnikov, S.; Gonick, H.C. Peroxynitrite but not nitric oxide donors destroys epinephrine: HPLC measurement and rat aorta contractility. Life Sci. 2004, 75, 2765-2773.
7. Kessler, P.; Bauersachs, J.; Busse, R.; Schini-Kerth, V.B. Inhibition of inducible nitric oxide synthase restores endothelium-dependent relaxations in proinflammatory mediator-induced blood vessels. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 1746-1755.
8. Virdis, A.; Colucci, R.; Fornai, M.; Blandizzi, C.; Duranti, E.; Pinto, S.; Bernardini, N.; Segnani, C.; Antonioli, L.; Taddei, S.; et al. Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: Role of inducible nitric-oxide synthase and oxidative stress. J. Pharmacol. Exp. Ther. 2005, 312, 945-953.
9. Eguchi, D.; D'Uscio, L.V.; Wambi, C.; Weiler, D.; Kovesdi, I.; O'Brien, T.; Katusic, Z.S. Inhibitory effect of recombinant iNOS gene expression on vasomotor function of canine basilar artery. Am. J. Physiol. Heart Circ. Physiol. 2002, 283, H2560-H2566.
10. Forstermann, U.; Sessa, W.C. Nitric oxide synthases: Regulation and function. Eur. Heart J. 2012, 33, 829-837.
11. Julou-Schaeffer, G.; Gray, G.A.; Fleming, I.; Schott, C.; Parratt, J.R.; Stoclet, J.C. Loss of vascular responsiveness induced by endotoxin involves L-Arginine pathway. Am. J. Physiol. 1990, 259, H1038-H1043.
12. Pittner, A.; Nalos, M.; Asfar, P.; Yang, Y.; Ince, C.; Georgieff, M.; Bruckner, U.B.; Radermacher, P.; Froba, G. Mechanisms of inducible nitric oxide synthase (iNOS) inhibition-related improvement of gut mucosal acidosis during hyperdynamic porcine endotoxemia. Intensiv. Care Med. 2003, 29, 312-316.
13. Petros, A.; Lamb, G.; Leone, A.; Moncada, S.; Bennett, D.; Vallance, P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res. 1994, 28, 34-39.
14. MacMicking, J.D.; Nathan, C.; Hom, G.; Chartrain, N.; Fletcher, D.S.; Trumbauer, M.; Stevens, K.; Xie, Q.W.; Sokol, K.; Hutchinson, N.; et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995, 81, 641-650.
15. Wang, Z.; Feng, K.; Yue, M.; Lu, X.; Zheng, Q.; Zhang, H.; Zhai, Y.; Li, P.; Yu, L.; Cai, M.; et al. A non-synonymous SNP in the NOS2 associated with septic shock in patients with sepsis in Chinese populations. Hum. Genet. 2013, 132, 337-346.
16. Xia, Y.; Zweier, J.L. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc. Natl. Acad. Sci. USA 1997, 94, 6954-6958.
17. Marfella, R.; di Filippo, C.; Esposito, K.; Nappo, F.; Piegari, E.; Cuzzocrea, S.; Berrino, L.; Rossi, F.; Giugliano, D.; D'Amico, M. Absence of inducible nitric oxide synthase reduces myocardial damage during ischemia reperfusion in streptozotocin-induced hyperglycemic mice. Diabetes 2004, 53, 454-462.
18. Pacher, P.; Beckman, J.S.; Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87, 315-424.
19. Liaudet, L.; Rosenblatt-Velin, N.; Pacher, P. Role of peroxynitrite in the cardiovascular dysfunction of septic shock. Curr. Vasc. Pharmacol. 2013, 11, 196-207.
20. Kuhlencordt, P.J.; Chen, J.; Han, F.; Astern, J.; Huang, P.L. Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation 2001, 103, 3099-3104.
21. Iadecola, C.; Zhang, F.; Xu, X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am. J. Physiol. 1995, 268, R286-R292.
22. Iadecola, C.; Zhang, F.; Casey, R.; Nagayama, M.; Ross, M.E. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 1997, 17, 9157-9164.
23. Li, H.; Xia, N.; Brausch, I.; Yao, Y.; Forstermann, U. Flavonoids from artichoke (Cynara scolymus L.) up-regulate endothelial-type nitric-oxide synthase gene expression in human endothelial cells. J. Pharmacol. Exp. Ther. 2004, 310, 926-932.
24. Rodriguez-Pascual, F.; Hausding, M.; Ihrig-Biedert, I.; Furneaux, H.; Levy, A.P.; Forstermann, U.; Kleinert, H. Complex contribution of the 3'-untranslated region to the expressional regulation of the human inducible nitric-oxide synthase gene. Involvement of the RNA-binding protein HuR. J. Biol. Chem. 2000, 275, 26040-26049.
25. Ishii, K.; Sheng, H.; Warner, T.D.; Forstermann, U.; Murad, F. A simple and sensitive bioassay method for detection of EDRF with RFL-6 rat lung fibroblasts. Am. J. Physiol. 1991, 261, H598-H603.
26. Pautz, A.; Art, J.; Hahn, S.; Nowag, S.; Voss, C.; Kleinert, H. Regulation of the expression of inducible nitric oxide synthase. Nitric. Oxide. 2010, 23, 75-93.
27. Hausding, M.; Witteck, A.; Rodriguez-Pascual, F.; von Eichel-Streiber, C.; Forstermann, U.; Kleinert, H. Inhibition of small G proteins of the rho family by statins or clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II. Br. J. Pharmacol. 2000, 131, 553-561.
28. Lattanzio, V.; Kroon, P.A.; Linsalata, V.; Cardinali, A. Globe artichoke: A functional food and source of nutraceutical ingredients. J. Funct. Foods 2009, 1, 131-144.
29. Saenz Rodriguez, T.; Garcia Gimenez, D.; de la Puerta Vazquez, R. Choleretic activity and biliary elimination of lipids and bile acids induced by an artichoke leaf extract in rats. Phytomedicine 2002, 9, 687-693.
30. Kucukgergin, C.; Aydin, A.F.; Ozdemirler-Erata, G.; Mehmetcik, G.; Kocak-Toker, N.; Uysal, M. Effect of artichoke leaf extract on hepatic and cardiac oxidative stress in rats fed on high cholesterol diet. Biol. Trace. Elem. Res. 2010, 135, 264-274.
31. Angelini, A.; di Pietro, R.; Centurione, L.; Castellani, M.L.; Conti, P.; Porreca, E.; Cuccurullo, F. Inhibition of P-glycoprotein-mediated transport by S-Adenosylmethionine and cynarin in multidrug-resistant human uterine sarcoma MES-SA/Dx5 cells. J. Biol. Regul. Homeost. Agents 2012, 26, 495-504.
32. Lopez-Molina, D.; Navarro-Martinez, M.D.; Rojas Melgarejo, F.; Hiner, A.N.; Chazarra, S.; Rodriguez-Lopez, J.N. Molecular properties and prebiotic effect of inulin obtained from artichoke (Cynara scolymus L.). Phytochemistry 2005, 66, 1476-1484.
33. Costabile, A.; Kolida, S.; Klinder, A.; Gietl, E.; Bauerlein, M.; Frohberg, C.; Landschutze, V.; Gibson, G.R. A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects. Br. J. Nutr. 2010, 104, 1007-1017.
34. Zhu, X.; Zhang, H.; Lo, R. Phenolic compounds from the leaf extract of artichoke (Cynara scolymus L.) and their antimicrobial activities. J. Agric. Food Chem. 2004, 52, 7272-7278.
35. Llorach, R.; Espin, J.C.; Tomas-Barberan, F.A.; Ferreres, F. Artichoke (Cynara scolymus L.) byproducts as a potential source of health-promoting antioxidant phenolics. J. Agric. Food Chem. 2002, 50, 3458-3464.
36. Wang, M.; Simon, J.E.; Aviles, I.F.; He, K.; Zheng, Q.Y.; Tadmor, Y. Analysis of antioxidative phenolic compounds in artichoke (Cynara scolymus L.). J. Agric. Food Chem. 2003, 51, 601-608.
37. Zapolska-Downar, D.; Zapolski-Downar, A.; Naruszewicz, M.; Siennicka, A.; Krasnodebska, B.; Koldziej, B. Protective properties of artichoke (Cynara scolymus) against oxidative stress induced in cultured endothelial cells and monocytes. Life Sci. 2002, 71, 2897-2808.
38. Juzyszyn, Z.; Czerny, B.; Pawlik, A.; Drozdzik, M. The effect of artichoke (Cynara scolymus L.) extract on ROS generation in HUVEC cells. Phytother. Res. 2008, 22, 1159-1161.
39. Perez-Garcia, F.; Adzet, T.; Canigueral, S. Activity of artichoke leaf extract on reactive oxygen species in human leukocytes. Free Radic. Res. 2000, 33, 661-665.
40. Jimenez-Escrig, A.; Dragsted, L.O.; Daneshvar, B.; Pulido, R.; Saura-Calixto, F. In vitro antioxidant activities of edible artichoke (Cynara scolymus L.) and effect on biomarkers of antioxidants in rats. J. Agric. Food Chem. 2003, 51, 5540-5545.
41. Magielse, J.; Verlaet, A.; Breynaert, A.; Keenoy, B.M.; Apers, S.; Pieters, L.; Hermans, N. Investigation of the in vivo antioxidative activity of Cynara scolymus (artichoke) leaf extract in the streptozotocin-induced diabetic rat. Mol. Nutr. Food Res. 2014, 58, 211-215.
42. Brown, J.E.; Rice-Evans, C.A. Luteolin-rich artichoke extract protects low density lipoprotein from oxidation in vitro. Free Radic. Res. 1998, 29, 247-255.
43. Wider, B.; Pittler, M.H.; Thompson-Coon, J.; Ernst, E. Artichoke leaf extract for treating hypercholesterolaemia. Cochrane. Database. Syst. Rev. 2013, 3, CD003335.
44. Bundy, R.; Walker, A.F.; Middleton, R.W.; Wallis, C.; Simpson, H.C. Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: A randomized, double blind placebo controlled trial. Phytomedicine 2008, 15, 668-675.
45. Rondanelli, M.; Giacosa, A.; Opizzi, A.; Faliva, M.A.; Sala, P.; Perna, S.; Riva, A.; Morazzoni, P.; Bombardelli, E. Beneficial effects of artichoke leaf extract supplementation on increasing HDL-cholesterol in subjects with primary mild hypercholesterolaemia: A double-blind, randomized, placebo-controlled trial. Int. J. Food Sci. Nutr. 2013, 64, 7-15.
46. Grande, S.; Bogani, P.; de Saizieu, A.; Schueler, G.; Galli, C.; Visioli, F. Vasomodulating potential of mediterranean wild plant extracts. J. Agric. Food Chem. 2004, 52, 5021-5026.
47. Roghani-Dehkordi, F.; Kamkhah, A.F. Artichoke leaf juice contains antihypertensive effect in patients with mild hypertension. J. Diet. Suppl. 2009, 6, 328-341.
48. Wittemer, S.M.; Ploch, M.; Windeck, T.; Muller, S.C.; Drewelow, B.; Derendorf, H.; Veit, M. Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans. Phytomedicine 2005, 12, 28-38.
49. Azzini, E.; Bugianesi, R.; Romano, F.; di Venere, D.; Miccadei, S.; Durazzo, A.; Foddai, M.S.; Catasta, G.; Linsalata, V.; Maiani, G. Absorption and metabolism of bioactive molecules after oral consumption of cooked edible heads of Cynara scolymus L. (cultivar Violetto di Provenza) in human subjects: A pilot study. Br. J. Nutr. 2007, 97, 963-969.
50. Dong, G.C.; Chuang, P.H.; Chang, K.C.; Jan, P.S.; Hwang, P.I.; Wu, H.B.; Yi, M.; Zhou, H.X.; Chen, H.M. Blocking effect of an immuno-suppressive agent, cynarin, on CD28 of T-cell receptor. Pharm. Res. 2009, 26, 375-381.
51. Wang, L.; Sweet, D.H. Interaction of natural dietary and herbal anionic compounds and flavonoids with human organic anion transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11). Evid. Based Complement. Alternat. Med. 2013, 2013, 612527.
52. Galvano, F.; La Fauci, L.; Lazzarino, G.; Fogliano, V.; Ritieni, A.; Ciappellano, S.; Battistini, N.C.; Tavazzi, B.; Galvano, G. Cyanidins: Metabolism and biological properties. J. Nutr. Biochem. 2004, 15, 2-11.
53. Serra, D.; Paixao, J.; Nunes, C.; Dinis, T.C.; Almeida, L.M. Cyanidin-3-glucoside suppresses cytokine-induced inflammatory response in human intestinal cells: Comparison with 5-Aminosalicylic acid. PLoS One 2013, 8, e73001.
54. Wang, Q.; Xia, M.; Liu, C.; Guo, H.; Ye, Q.; Hu, Y.; Zhang, Y.; Hou, M.; Zhu, H.; Ma, J.; et al. Cyanidin-3-O-beta-glucoside inhibits iNOS and COX-2 expression by inducing liver X receptor alpha activation in THP-1 macrophages. Life Sci. 2008, 83, 176-184.
55. Sorrenti, V.; di Giacomo, C.; Acquaviva, R.; Bognanno, M.; Grilli, E.; D'Orazio, N.; Galvano, F. Dimethylarginine dimethylaminohydrolase/nitric oxide synthase pathway in liver and kidney: Protective effect of cyanidin 3-O-beta-D-glucoside on ochratoxin-A toxicity. Toxins (Basel) 2012, 4, 353-363.
56. Min, S.W.; Ryu, S.N.; Kim, D.H. Anti-inflammatory effects of black rice, cyanidin-3-O-beta-Dglycoside, and its metabolites, cyanidin and protocatechuic acid. Int. Immunopharmacol. 2010, 10, 959-966.
57. Kim, J.M.; Kim, J.S.; Yoo, H.; Choung, M.G.; Sung, M.K. Effects of black soybean [Glycine max (L.) Merr.] seed coats and its anthocyanidins on colonic inflammation and cell proliferation in vitro and in vivo. J. Agric. Food Chem. 2008, 56, 8427-8433.
58. Schmidt, N.; Pautz, A.; Art, J.; Rauschkolb, P.; Jung, M.; Erkel, G.; Goldring, M.B.; Kleinert, H. Transcriptional and post-transcriptional regulation of iNOS expression in human chondrocytes. Biochem. Pharmacol. 2010, 79, 722-732.
59. Xia, N.; Strand, S.; Schlufter, F.; Siuda, D.; Reifenberg, G.; Kleinert, H.; Forstermann, U.; Li, H. Role of SIRT1 and FOXO factors in eNOS transcriptional activation by resveratrol. Nitric Oxide 2013, 32, 29-35.
60. Li, H.; Forstermann, U. Structure-Activity relationship of staurosporine analogs in regulating expression of endothelial nitric-oxide synthase gene. Mol. Pharmacol. 2000, 57, 427-435.